Mustang Bio
MBIO
64 hedge funds and large institutions have $24M invested in Mustang Bio in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
16% more funds holding
Funds holding: 55 → 64 (+9)
0% less ownership
Funds ownership: 0.03% → 0.03% (-0%)
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
33% less capital invested
Capital invested by funds: $35.8M → $24M (-$11.8M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $122K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$261K |
| 2 |
DC
Davenport & Co
Richmond,
Virginia
|
+$259K |
| 3 |
FIA
FNY Investment Advisers
New York
|
+$241K |
| 4 |
Squarepoint
New York
|
+$241K |
| 5 |
Renaissance Technologies
New York
|
+$200K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$751K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$677K |
| 3 |
Morgan Stanley
New York
|
-$138K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$107K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$89.7K |
MBIO Hedge Fund Activity: Q1 2020 in Review
64 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2020, worth a combined $24M — down 33% from $35.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MBIO positions and 5 closed out — a net gain of 9 holders — while 14 added to existing stakes and 15 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $261K. The largest seller was Nexpoint Asset Management, cutting an estimated $751K.
- 64 institutional investors held Mustang Bio (MBIO) as of Q1 2020, up from 55 in Q4 2019.
- Funds reported $24M of Mustang Bio stock for Q1 2020, down 33% quarter-over-quarter.
- 14 funds opened new Mustang Bio positions in Q1 2020 and 5 closed out, a net change of +9 holders.
- The largest Mustang Bio buyer in Q1 2020 was Acadian Asset Management, an estimated $261K added.
- The largest Mustang Bio seller in Q1 2020 was Nexpoint Asset Management, an estimated $751K sold.
Based on aggregated 13F filings for Q1 2020.